Cingulate Inc., a biopharmaceutical company, has announced a live event featuring investor and board member Peter J. Werth and Chairman & CEO Shane J. Schaffer. The event, called Benzinga All Access, will take place on Friday, May 3, 2024, at 12:10 p.m. EST. Peter J. Werth, Founder and CEO of ChemWerth Inc., will discuss his background as a successful pharmaceutical executive and entrepreneur, as well as his perspective on capital markets and the biotech industry. Dr. Schaffer will provide an overview of the company and recap recent clinical and business updates from Cingulate. The event can be viewed live on Benzinga’s YouTube channel, Benzinga All Access, and will also be available for viewing on Cingulate’s website at cingulate.com/investors.